GC-MS determination of guanidinoacetate in urine and plasma

Journal of Inherited Metabolic Disease

Volumn 20, Issue 3, 1997, Pages 450-452

  Hunneman, D H ^a   Hanefeld, F ^a  

^a UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CREATINE; GUANIDINOACETIC ACID; METHYLTRANSFERASE; UNCLASSIFIED DRUG;

BLOOD LEVEL; CASE REPORT; CONFERENCE PAPER; DIAGNOSTIC ACCURACY; ENZYME DEFICIENCY; EXTRAPYRAMIDAL SYMPTOM; GAS CHROMATOGRAPHY; HUMAN; INBORN ERROR OF METABOLISM; MALE; MASS SPECTROMETRY; MUSCLE HYPOTONIA; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRESCHOOL CHILD; SCREENING TEST; URINE LEVEL;

EID: 0030759324     PISSN: 01418955     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1005383507547     Document Type: Conference Paper

References (3)

1. Malcolm SL, Marten TR (1976) Determination of debrisoquin and its 4-hydroxy metabolite in plasma by gas chromatography/mass spectrometry. Anal Chem 48: 807-810.
2. Marescau T, Qureshi IA, de Deyn P, Letarte J, Ryba R, Lowentale A (1985) Guanidino compounds in plasma, urine and cerebrospinal fluid of hyperargininemic patients during therapy. Clin Chim Acta 146: 21-27.
3. Stöckler S, Holzbach U, Hanefeld F, et al (1994) Creatine deficiency in the brain: a new, treatable inborn error of metabolism. Pediatr Res 36: 409-413.